Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Apr 21, 2022 7:37pm
117 Views
Post# 34622299

RE:RE:RE:RE:RE:RE:Bullboard...

RE:RE:RE:RE:RE:RE:Bullboard...Funny Rumpl3StiltSkin that both "Gorf79 with an agenda" and his buddy "FGPStock with an agenda" don't comment on your example of Briacell going down -30% the day after a Fast Track Approval designation.  Right there, you can see their agenda.

They were both insulted that we confronted their weak arguments and opposed them with facts. 

They thought that their:

-  "botched trial design" argument,
-  "press release didn't include bullet points type of format" argument,
-  "TLT management should have known about existence of shorts" argument,
-  "TLT was responsabie of the bladder size issue" argument

were exact and they attacked TLT management, when in fact, all of these were goofy arguments at best.  And when we opposed them with facts and perspectives, they say with don't accept differences of opinion.  No.  It's just that we don't accept people with a hidden agenda that cannot even come up prepared with legitimate arguments that have a minimum of seriousness and credibility.  


<< Previous
Bullboard Posts
Next >>